Task Group Charge

To address the broad challenges related to lung cancer survivorship across the care continuum, and the influence that stigma and nihilism have on quality of life, cancer care and prognosis.

Leadership

Jamie L. Studts, PhD

Task Group Chair
Steering Committee Member
University of Colorado School of Medicine

Lisa Carter-Harris

Lisa Carter-Harris, PhD, APRN, ANP-C, FAAN

Task Group Vice Chair
Memorial Sloan Kettering Cancer Center

Task Group Members

Nancy Alvey
Survivor and Lung Cancer Advocate, Kentucky LEADS Collaborative

Abbie Begnaud, MD
University of Minnesota

Deborah Brown
American Lung Association

Andrew Chang, MD
University of Michigan

Deena Cook
Survivor and Lung Cancer Advocate, GO2 Foundation for Lung Cancer

Dusty Donaldson, MA
Survivor and Lung Cancer Advocate, Dusty Joy Foundation (LiveLung)

Heidi Hamann, PhD
University of Arizona

Drew Moghanaki, MD, MPH
Emory Healthcare and Atlanta VA Healthcare System

Jamie Ostroff, PhD*
Memorial Sloan Kettering Cancer Center

James Pantelas
Survivor and Lung Cancer Advocate, GO2 Foundation for Lung Cancer

Elyse Park, PhD, MPH
Massachusetts General Hospital

Maureen Rigney, LISCW
GO2 Foundation for Lung Cancer

Elizabeth Rohan, PhD, MSW
Centers for Disease Control and Prevention

Pamela Samson, MD, MPHS
Washington University School of Medicine in St. Louis

Joan Schiller, MD
Lung Cancer Research Foundation

Brendon Stiles, MD
Weill Cornell Medicine

(*) indicates Steering Committee member

Opportunities For Intervention/Influence:

  • Meet the survivorship needs of patients and families living with, through and beyond lung cancer
  • Address stigma across the lung cancer control continuum with the goal of eliminating stigma as an obstacle to quality of life, care delivery, and health outcomes
  • Identify and address the causes and impact¬†of nihilism regarding lung cancer risk reduction, screening, diagnosis and treatment